Canada Authorizes AstraZeneca’s Drug for COVID Prevention

Canada on Thursday authorized British drugmaker AstraZeneca Plc's antibody-based therapy for preventing COVID-19 infections, giving itself another weapon against the disease as cases rise in the country.
Reuters Health Information
Canada on Thursday authorized British drugmaker AstraZeneca Plc’s antibody-based therapy for preventing COVID-19 infections, giving itself another weapon against the disease as cases rise in the country.
Reuters Health Information